The reported prevalence of BRCA1/2 germline pathogenic variants in Asian patients with familial BC ranges from 8·0% to 31·8% and in those with young-onset BC, it ranges from 2·8% to 21·4% (5). This evidence concerns the gene BRCA1 and breast cancer.